A local startup company, TypeZero Technologies, and a University of Virginia (UVA) research program have attracted national attention for the development of their artificial pancreas system.
CNBC.com reported that a team of researchers led by Dr. Boris Kovatchev, director of the UVA Center for Diabetes Technology, will begin final clinical trials this summer on an artificial pancreas system that was developed at UVA and is being commercialized by TypeZero Technologies.
The CNBC report quotes Dr. Marc Breton, associate professor at UVA's Center for Diabetes Technology. "The technology behind artificial pancreas systems is being improved and refined daily. The algorithms they are based on are resulting in better and better outcomes. For people with type I diabetes, it's quite a hopeful time."
Learn more about Charlottesville-based, TypeZero Technologies.